Study title:
"Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies.
" "C1538d/312/AD/US et al.
SB Wigal, et al., Primary Care Companion to the Journal of Clinical Psychiatry 2006, 8(6): 352-60.
"
"Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies.
" "C1538d/312/AD/US et al.
SB Wigal, et al., Primary Care Companion to the Journal of Clinical Psychiatry 2006, 8(6): 352-60.
"
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Nervous System Diseases
|
Brands: |
MAH holders: |
Assessment: |
Active substance: MODAFINIL |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|